278 million dollars! Takeda's Asia Pacific rights to sell 18 drugs to celltrion
278 million dollars! Takeda\'s Asia Pacific rights to sell 18 drugs to celltrion
2020-06-12
Too high NDMA level in metformin! FDA requires 5 companies to recall
Too high NDMA level in metformin! FDA requires 5 companies to recall
2020-05-29
Loxo-292 approved! Retevmo (selpercatinib), an FDA approved Lilly RET inhibitor, for lung and thyroid cancer patients
Loxo-292 approved! Retevmo (selpercatinib), an FDA approved Lilly RET inhibitor, for lung and thyroid cancer patients
2020-05-09
Good news! Hqp1351, the core product under development of AXA pharmaceutical, has obtained the qualification of fast tra
Good news! Hqp1351, the core product under development of AXA pharmaceutical, has obtained the qualification of fast track for FDA review, and meets the milestone again
2020-05-09
Spinal muscular atrophy (SMA) the first oral medicine! Roche risdiplam's US review has been delayed for 3 months, and wi
Spinal muscular atrophy (SMA) the first oral medicine! Roche risdiplam\'s US review has been delayed for 3 months, and will soon submit an application for listing in China!
2020-04-29
The first gene therapy for spinal muscular atrophy (SMA) in the world! Zolgensma of Novartis is recommended and approved
The first gene therapy for spinal muscular atrophy (SMA) in the world! Zolgensma of Novartis is recommended and approved by CHMP of EU!
2020-04-29
[recruitment of gastric cancer patients] Clinical Study of hx008 injection combined with chemotherapy in the treatment o
[recruitment of gastric cancer patients] Clinical Study of hx008 injection combined with chemotherapy in the treatment of advanced gastric cancer
2020-04-25
Ozanimod: a potential drug for multiple sclerosis
Ozanimod: a potential drug for multiple sclerosis
2020-04-25
